glutathione gastritis Nineteen-year follow-up of a patient with severe synthetase deficiency Glutathione Participation in the Prevention

Reviews favor oral/topical for safety

Danaei GH, Memar B, Ataee R, Karami M

The limited human data available indicate that both peptides appear to be generally well-tolerated, yet comprehensive safety and efficacy assessments from large, well-designed clinical trials are absent

A phase I safety study in healthy adults confirmed that subcutaneous MOTS-c injections at doses up to 10 mg produced no serious adverse events, with a pharmacokinetic profile supporting once-daily or every-other-day dosing [3]

Comparison of BPC 157 and TB 500: Oral vs

Avoid harsh fairness creams, steroid creams, and strong home remedies because they can damage the skin and worsen pigmentation over time